Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
3.00 |
| Stent Length (mm) |
09, 15 & 30 |
| CAT No |
RSINT30009X, RSINT30015X & RSINT30030X |
| Catheter Length |
300 cm |
Resolute Integrity is a drug-eluting stent (DES) and balloon catheter that offers excellent deliverability and flexibility for percutaneous coronary interventions.
Advanced Stent Design for Optimal PerformanceThe Resolute Integrity features a continuous sinusoidal design, crafted from cobalt alloy for superior flexibility and vessel conformity. This design enhances deliverability in challenging anatomy, ensuring efficient and stable stenting during percutaneous coronary interventions.
Biocompatible Drug-Eluting TechnologyUtilizing the BioLinxTM durable polymer, the stent provides a controlled release of zotarolimus, a proven antiproliferative agent. This mechanism significantly lowers the risk of restenosis while ensuring balance between vessel healing and long-term efficacy.
Safe and Visible in Clinical UseWith excellent radiopacity, clinicians benefit from superior fluoroscopic visibility, facilitating precise placement. The stent is MR Conditional and comes sterilized in double-pouch packaging, ensuring product safety from storage to implantation.
FAQ's of Medtronic Resolute Integrity DES Drug-eluting Stent (SD 3.00):
Q: How does the Resolute Integrity DES improve outcomes in coronary artery disease treatment?
A: The stent combines targeted zotarolimus drug delivery with the IntegrityTM continuous sinusoidal design, offering optimal vessel support, reducing restenosis rates, and improving procedural success for both de novo and restenotic lesions.
Q: What is the recommended process for implanting this drug-eluting stent?
A: Implantation is performed via percutaneous coronary intervention (PCI) using a rapid exchange delivery catheter. The stent is precisely positioned under fluoroscopy thanks to its excellent radiopacity, then deployed by balloon expansion.
Q: When is the Resolute Integrity DES indicated for use?
A: It is indicated for the treatment of de novo and restenotic lesions in native coronary arteries, making it suitable for patients undergoing PCI for coronary artery disease.
Q: Where can the Resolute Integrity DES be used in terms of procedure locations?
A: The device is designed for use in specialized cardiovascular catheterization labs equipped for percutaneous coronary interventions, and is suitable for hospital, interventional clinic, and specialty cardiac centers.
Q: What are the benefits of the BioLinxTM polymer in this stent?
A: The BioLinxTM durable polymer provides a biocompatible platform for smooth zotarolimus drug release, promoting vessel healing while minimizing inflammation and late restenosis.
Q: Is the Medtronic Resolute Integrity DES approved for international use?
A: Yes, the stent is both CE Marked and US FDA approved, meeting rigorous international standards for safety and efficacy.
Q: How should the stent be stored prior to use?
A: Store the stent in a cool, dry place away from direct sunlight as per provided instructions; keep its sterile, double-pouched packaging intact until just before the intervention.